Yousif Capital Management’s Cytokinetics CYTK Stock Holding History

Yousif Capital Management’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.29M	Buy	38,651 +1,732	+5%	+$124K	0.04%	452
2026 Q1	$2.43M	Sell	36,919 -1,745	-5%	-$111K	0.03%	572
2025 Q4	$2.47M	Buy	38,664 +25	+0.1%	+$1.55K	0.03%	607
2025 Q3	$2.12M	Sell	38,639 -2,538	-6%	-$105K	0.02%	688
2025 Q2	$1.36M	Sell	41,177 -483	-1%	-$16.8K	0.01%	955
2025 Q1	$1.67M	Sell	41,660 -1,126	-3%	-$51.7K	0.02%	821
2024 Q4	$2.01M	Sell	42,786 -1,487	-3%	-$77.2K	0.02%	751
2024 Q3	$2.34M	Sell	44,273 -4,823	-10%	-$269K	0.03%	685
2024 Q2	$2.66M	Buy	49,096 +3,663	+8%	+$221K	0.03%	594
2024 Q1	$3.19M	Sell	45,433 -3,496	-7%	-$270K	0.04%	552
2023 Q4	$4.09M	Sell	48,929 -1,494	-3%	-$54.1K	0.05%	403
2023 Q3	$1.49M	Sell	50,423 -2,877	-5%	-$95.8K	0.02%	908
2023 Q2	$1.74M	Sell	53,300 -2,588	-5%	-$95.8K	0.02%	851
2023 Q1	$1.97M	Sell	55,888 -6,950	-11%	-$284K	0.03%	785
2022 Q4	$2.88M	Sell	62,838 -13,145	-17%	-$566K	0.04%	550
2022 Q3	$3.68M	Buy	75,983 +5,718	+8%	+$275K	0.05%	381
2022 Q2	$2.76M	Sell	70,265 -4,985	-7%	-$201K	0.04%	582
2022 Q1	$2.77M	Buy	75,250 +905	+1%	+$32.2K	0.03%	712
2021 Q4	$3.39M	Buy	+74,345	New	+$2.87M	0.04%	600

Other funds holding CYTK

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

EOJOAM

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

MCP

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Yousif Capital Management's CYTK Position: Q2 2026 in Review

Yousif Capital Management increased its Cytokinetics (CYTK) stake by 4.7% in Q2 2026, buying an estimated $124K and bringing the position to 38,651 shares worth $3.29M. The position accounts for 0.04% of the portfolio, ranked #452.

Yousif Capital Management first reported a position in CYTK in Q4 2021 and has held it in 19 quarters since. The position peaked at $4.09M in Q4 2023. 51 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

Yousif Capital Management held 38,651 shares of Cytokinetics worth $3.29M as of Q2 2026.
Yousif Capital Management bought 1,732 Cytokinetics shares in Q2 2026, an estimated $124K.
Cytokinetics made up 0.04% of Yousif Capital Management's portfolio in Q2 2026, its #452 holding.
Yousif Capital Management first reported a position in Cytokinetics in Q4 2021 and has held it in 19 quarters since.
Yousif Capital Management's Cytokinetics position peaked at $4.09M in Q4 2023.
51 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.